Green synthesis of Al2O3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa

World Journal of Microbiology and Biotechnology

Volumn 31, Issue 1, 2015, Pages 153-164

  Ansari, Mohammad A ^a,b   Khan, Haris M ^a   Alzohairy, Mohammad A ^b   Jalal, Mohammad ^a   Ali, Syed G ^a   Pal, Ruchita ^c   Musarrat, Javed ^d  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b Buraydah Private Colleges   (Saudi Arabia)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

^d ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Al2O3 NPs; DLS; Green synthesis; HR TEM; Lemongrass; XRD; Zeta potential

Indexed keywords

ALUMINA; ALUMINUM OXIDE; ATOMIC FORCE MICROSCOPY; BACTERIA; CELL MEMBRANES; COST EFFECTIVENESS; CYTOLOGY; DRUG DELIVERY; ELECTRONS; LIGHT SCATTERING; MEDICAL APPLICATIONS; METALS; NANOPARTICLES; PHARMACODYNAMICS; SCANNING ELECTRON MICROSCOPY; SPECTRUM ANALYSIS; SYNTHESIS (CHEMICAL); X RAY DIFFRACTION; ZETA POTENTIAL;

ANTI-BACTERIAL ACTIVITY; BACTERIAL CELL SURFACE; BIOMEDICAL APPLICATIONS; GREEN SYNTHESIS; INTRACELLULAR OXIDATIVE STRESS; LEMONGRASS; LIGHT SCATTERING TECHNIQUES; MINIMAL INHIBITORY CONCENTRATION;

HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ALUMINUM OXIDE; ANTI-BACTERIAL AGENTS; NANOPARTICLES; PLANT EXTRACTS;

CELL MEMBRANE; CHEMICAL SYNTHESIS; CYMBOPOGON; DRUG EFFECTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; ULTRASTRUCTURE; X-RAY DIFFRACTION;

ALUMINUM OXIDE; ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CYMBOPOGON; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; X-RAY DIFFRACTION;

EID: 84938409073     PISSN: 09593993     EISSN: 15730972     Source Type: Journal    
DOI: 10.1007/s11274-014-1757-2     Document Type: Article

References (53)

1. 2, and ZnO water suspensions. Water Res 40:3527–3532
2. Ansari MA, Khan HM, Khan AA, Sultan A, Azam A, Shahid M, Shujatullah F (2011) Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med 3:141–146
3. Ansari MA, Khan HM, Khan AA, Sultan A, Azam A (2012a) Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India. Appl Microbiol Biotechnol 94:467–477
4. Ansari MA, Khan HM, Khan AA, Sultan A, Azam A (2012b) Characterization of clinical strains of MSSA, MRSA and MRSE isolated from skin and soft tissue infections and the antibacterial activity of ZnO nanoparticles. World J Microbiol Biotechnol 28:1605–1613
5. 3 nanoparticles against multi drug resistance strains of Staphylococcus aureus isolated from skin exudates. J Nanopart Res. doi:10.1007/s11051-013-1970-1
6. Ansari MA, Khan HM, Khan AA, Ahmad MK, Mahdi AA, Pal R, Cameotra SS (2014a) Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomolecules. J Basic Microbiol 54(9):905–915
7. 3 nanoparticles with Escherichia coli and their cell envelope biomolecules. J Appl Microbiol 116(4):772–783
8. Ansari MA, Khan HM, Khan AA, Cameotra SS, Saquib Q, Musarrat J (2014c) Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa. J Basic Microbiol 54:688–699
9. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P (2010) In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella microsome assay. Toxicol In Vitro 24:1871–1876
10. Bereket W, Hemalatha K, Getenet B, Wondwossen T, Solomon A, Zeynudin A, Kannan S (2012) Update on bacterial nosocomial infections. Euro Rev Med Pharmacol Sci 16:1039–1044
11. Bush K (2001) New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:1085–1089
12. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211–1233
13. CLSI (2006) Performance standards for antimicrobial susceptibility testing, Fifteenth Informational Supplement, CLSI document, M100-S16, vol 26-3; M7-A7, vol 26-2; M2-A9, vol 26-1. Wayne, PA, US
14. Driscoll CT, Schecher WD (1990) The chemistry of aluminum in the environment. Environ Geochem Health 12:28–50
15. Dundar D, Otkun M (2010) In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains. Yonsei Med J 51:111–116
16. Franco MR, Caiaffa-Filho HH, Burattini MN, Rossi F (2010) Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 65:825–829
17. Griffitt RJ, Luo J, Gao J, Bonzongo JC, Barber DS (2008) Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms. Environ Toxicol Chem 27:1972–1978
18. Huh AJ, Kwon YJ (2011) “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156:128–145
19. Jiang W, Mashayekhi H, Xing B (2009) Bacterial toxicity comparison between nano- and micro-scale oxide particles. Environ Pollut 157:1619–1625
20. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V (2010) A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328–346
21. Keller AA, Wang H, Zhou D, Lenihan HS, Cherr G, Cardinal BJ, Miller R, Ji Z (2010) Stability and aggregation of metal oxide nanoparticles in natural aqueous matrices. Environ Sci Technol 44:962–1967
22. Lagatolla C, Edalucci E, Dolzani L, Riccio ML, Luca FD, Medessi E, Rossolini GM, Tonin EA (2006) Molecular evolution of metallo-β-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J Clin Microbiol 44:2348–2353
23. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH (2001) Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7:88–91
24. Lee K, Lee WG, Uh Y, Ha AY, Cho J, Chong Y (2003) VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 9:868–871
25. Li M, Zhu L, Lin D (2011) Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol 45:1977–1983
26. Liu X, Luo L, Ding Y, Xu Y (2011) Amperometric biosensors based on alumina nanoparticles-chitosan-horseradish peroxidase nanobiocomposites for the determination of phenolic compounds. Analyst 136:696–701
27. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634–640
28. Livermore DM, Woodford N (2000) Carbapenemases: a problem in waiting? Curr Opin Microbiol 3:489–495
29. Mansour HM, Rhee YS, Wu X (2009) Nanomedicine in pulmonary delivery. Int J Nanomed 4:299–319
30. Monteiro-Riviere NA, Oldenburg SJ, Inman AO (2010) Interactions of aluminum nanoparticles with human epidermal keratinocytes. J Appl Toxicol 30:276–285
31. Mukherjee A, Sadiq LM, Prathna TC, Chandreasekaran N (2011) Antimicrobial activity of aluminium oxide nanoparticles for potential clinical applications. In: Mendez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances, vol. 1. FORMATEX Microbiology, Series No. 3, pp 245–251
32. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM (2008) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253
33. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627
34. 3 nanoparticles at low exposure levels to a freshwater bacterial isolate. Chem Res Toxicol 24:1899–1904
35. Pakrashi S, Dalai S, Prathna TC, Trivedi S, Myneni R, Raichur AM, Chandrasekaran N, Mukherjee A (2013) Cytotoxicity of aluminium oxide nanoparticles towards fresh water algal isolate at low exposure concentrations. Aqua Toxicol 132:34–45
36. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55:4943–4960
37. Paul M, Yahav D, Bivas A, Fraser A, Leibovici L (2010) Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Sys Rev 11:CD005197
38. Poole K (2011) Pseudomonas aeruginosa: resistance to the max. Front Microbiol 65:1–13
39. Qu TT, Zhang JL, Wang J, Tao J, Yu YS, Chen YG, Zhou JY, Li LJ (2009) Evaluation of phenotypic tests for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains in China. J Clin Microbiol 47:1136–1142
40. Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440–458
41. Sader HS, Reis AO, Silbert S, Gales AC (2005) IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect 11:73–76
42. Sadiq MI, Chowdhury B, Chandrasekaran N, Mukherjeem A (2009) Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles. Nanomedicine 5:282–286
43. Santos-Magalhães NS, Mosqueira VC (2010) Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 2:560–575
44. Sawai J, Igarashi H, Hashimoto A, Kokugan T, Shimizu M (1995) Evaluation of growth inhibitory effect of ceramics powder slurry on bacteria by conductance method. J Chem Eng Jpn 28:288–293
45. Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA (2014) Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital. Saudi J Biol Sci. doi:10.1016/j.sjbs.2014.06.001
46. Simon-Deckers A, Loo S, Mayne-L’hermite M, Herlin-Boime N, Menguy N, Reynaud C, Gouget B, Carriere M (2009) Size-, composition- and shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ Sci Technol 43:8423–8429
47. Skwarczynski M, Toth I (2011) Peptide-based subunit nanovaccines. Curr Drug Deliv 8:282–289
48. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–182
49. Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA (2010) New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev 62:547–559
50. 2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 40:6151–6156
51. Uyeda R (1991) Studies of ultrafine particles in Japan: crystallography. Methods of preparation and technological applications. Prog Mater Sci 35:96
52. Weir E, Lawlor A, Whelan A, Regan F (2008) The use of nanoparticles in anti-microbial materials and their characterization. Analyst 133:835–845
53. Yousefi S, Farajnia S, Nahaei MR, Akhi MT, Ghotaslou R, Soroush MH, Naghili B, Jazani NH (2010) Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis 68:322–325